

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA unwinding involved in DNA replication (GO:0006268) | 4.60676235 |
| 2 | NIK/NF-kappaB signaling (GO:0038061) | 4.40270014 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.07258073 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.07258073 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 4.07258073 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.07258073 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.07258073 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.07258073 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.95158580 |
| 10 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.90070965 |
| 11 | detection of bacterium (GO:0016045) | 3.83557945 |
| 12 | positive regulation of B cell differentiation (GO:0045579) | 3.79459000 |
| 13 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.75395778 |
| 14 | Peyers patch development (GO:0048541) | 3.75395778 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.73813091 |
| 16 | protein localization to kinetochore (GO:0034501) | 3.69042269 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.61463811 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.61463811 |
| 19 | negative regulation of RNA splicing (GO:0033119) | 3.59395424 |
| 20 | detection of other organism (GO:0098543) | 3.57795387 |
| 21 | regulation of translational fidelity (GO:0006450) | 3.56472735 |
| 22 | formation of translation preinitiation complex (GO:0001731) | 3.50373291 |
| 23 | protein localization to chromosome, centromeric region (GO:0071459) | 3.47307830 |
| 24 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.46158142 |
| 25 | negative regulation of mRNA metabolic process (GO:1903312) | 3.45970075 |
| 26 | response to muramyl dipeptide (GO:0032495) | 3.45027948 |
| 27 | nucleosome disassembly (GO:0006337) | 3.44761998 |
| 28 | protein-DNA complex disassembly (GO:0032986) | 3.44761998 |
| 29 | ribosomal small subunit assembly (GO:0000028) | 3.43898849 |
| 30 | viral transcription (GO:0019083) | 3.43472797 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.38554216 |
| 32 | negative regulation of cell killing (GO:0031342) | 3.38554216 |
| 33 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.38047113 |
| 34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.34555652 |
| 35 | positive thymic T cell selection (GO:0045059) | 3.29774995 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 3.28971335 |
| 37 | mitotic nuclear envelope disassembly (GO:0007077) | 3.28127521 |
| 38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.28033893 |
| 39 | B cell receptor signaling pathway (GO:0050853) | 3.26497729 |
| 40 | translational termination (GO:0006415) | 3.26362793 |
| 41 | negative regulation of mRNA processing (GO:0050686) | 3.26217718 |
| 42 | mannose metabolic process (GO:0006013) | 3.23265056 |
| 43 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.22003385 |
| 44 | maternal placenta development (GO:0001893) | 3.21426561 |
| 45 | regulation of gamma-delta T cell activation (GO:0046643) | 3.21257079 |
| 46 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.20505261 |
| 47 | negative regulation of histone methylation (GO:0031061) | 3.20249558 |
| 48 | regulation of monocyte differentiation (GO:0045655) | 3.20174878 |
| 49 | leukocyte aggregation (GO:0070486) | 3.19101011 |
| 50 | T cell selection (GO:0045058) | 3.16610978 |
| 51 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.15207890 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 3.14631856 |
| 53 | mitotic chromosome condensation (GO:0007076) | 3.13715761 |
| 54 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.13592596 |
| 55 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.13276677 |
| 56 | positive regulation of histone deacetylation (GO:0031065) | 3.12452472 |
| 57 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.12360742 |
| 58 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.10884915 |
| 59 | translational elongation (GO:0006414) | 3.10655201 |
| 60 | peptidyl-lysine dimethylation (GO:0018027) | 3.10214186 |
| 61 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.09522956 |
| 62 | heterochromatin organization (GO:0070828) | 3.07893351 |
| 63 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.06866139 |
| 64 | modulation by virus of host process (GO:0019054) | 3.04682144 |
| 65 | regulation of chromatin binding (GO:0035561) | 3.03712741 |
| 66 | regulation of B cell differentiation (GO:0045577) | 3.03602240 |
| 67 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.02573597 |
| 68 | maturation of SSU-rRNA (GO:0030490) | 3.02256927 |
| 69 | response to peptidoglycan (GO:0032494) | 3.01557206 |
| 70 | nuclear envelope disassembly (GO:0051081) | 2.99278051 |
| 71 | membrane disassembly (GO:0030397) | 2.99278051 |
| 72 | thymic T cell selection (GO:0045061) | 2.98870248 |
| 73 | histone H3-K36 demethylation (GO:0070544) | 2.97100864 |
| 74 | pre-miRNA processing (GO:0031054) | 2.96806971 |
| 75 | DNA strand elongation (GO:0022616) | 2.96799246 |
| 76 | IMP biosynthetic process (GO:0006188) | 2.94939834 |
| 77 | type I interferon signaling pathway (GO:0060337) | 2.94856153 |
| 78 | cellular response to type I interferon (GO:0071357) | 2.94856153 |
| 79 | response to type I interferon (GO:0034340) | 2.93594076 |
| 80 | negative regulation of innate immune response (GO:0045824) | 2.92116744 |
| 81 | DNA duplex unwinding (GO:0032508) | 2.91979401 |
| 82 | positive T cell selection (GO:0043368) | 2.91759989 |
| 83 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.91086923 |
| 84 | response to host immune response (GO:0052572) | 2.91086923 |
| 85 | translational initiation (GO:0006413) | 2.90796099 |
| 86 | regulation of superoxide anion generation (GO:0032928) | 2.88643910 |
| 87 | germinal center formation (GO:0002467) | 2.88173355 |
| 88 | negative thymic T cell selection (GO:0045060) | 2.86818860 |
| 89 | DNA geometric change (GO:0032392) | 2.86541397 |
| 90 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.85698408 |
| 91 | nuclear pore complex assembly (GO:0051292) | 2.84726383 |
| 92 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.82486473 |
| 93 | neutrophil activation involved in immune response (GO:0002283) | 2.82361202 |
| 94 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.81849217 |
| 95 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.80944235 |
| 96 | nuclear pore organization (GO:0006999) | 2.79770007 |
| 97 | negative T cell selection (GO:0043383) | 2.79233788 |
| 98 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.78010075 |
| 99 | mRNA stabilization (GO:0048255) | 2.75755382 |
| 100 | RNA stabilization (GO:0043489) | 2.75755382 |
| 101 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.75617923 |
| 102 | negative regulation of B cell apoptotic process (GO:0002903) | 2.74838473 |
| 103 | cellular response to interleukin-4 (GO:0071353) | 2.74300875 |
| 104 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.72508047 |
| 105 | response to host (GO:0075136) | 2.72508047 |
| 106 | response to host defenses (GO:0052200) | 2.72508047 |
| 107 | dosage compensation (GO:0007549) | 2.71681916 |
| 108 | viral mRNA export from host cell nucleus (GO:0046784) | 2.71424838 |
| 109 | protein localization to chromosome (GO:0034502) | 2.70901896 |
| 110 | modulation by symbiont of host cellular process (GO:0044068) | 2.70619434 |
| 111 | regulation of histone H3-K9 methylation (GO:0051570) | 2.70389703 |
| 112 | gene silencing (GO:0016458) | 2.70294494 |
| 113 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.70190034 |
| 114 | T cell migration (GO:0072678) | 2.69970084 |
| 115 | negative regulation of phagocytosis (GO:0050765) | 2.67730239 |
| 116 | IMP metabolic process (GO:0046040) | 2.67404120 |
| 117 | regulation of antigen processing and presentation (GO:0002577) | 2.67369672 |
| 118 | endothelial tube morphogenesis (GO:0061154) | 2.66732865 |
| 119 | morphogenesis of an endothelium (GO:0003159) | 2.66732865 |
| 120 | histone H4 deacetylation (GO:0070933) | 2.65779769 |
| 121 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.65092808 |
| 122 | regulation of RNA export from nucleus (GO:0046831) | 2.63674717 |
| 123 | mature B cell differentiation involved in immune response (GO:0002313) | 2.62743176 |
| 124 | positive regulation of antigen processing and presentation (GO:0002579) | 2.62285576 |
| 125 | pinocytosis (GO:0006907) | 2.62020340 |
| 126 | positive regulation of protein deacetylation (GO:0090312) | 2.60070638 |
| 127 | cellular extravasation (GO:0045123) | 2.59375037 |
| 128 | ncRNA 3-end processing (GO:0043628) | 2.59283531 |
| 129 | gene silencing by RNA (GO:0031047) | 2.58990591 |
| 130 | protein complex disassembly (GO:0043241) | 2.58885123 |
| 131 | detection of external biotic stimulus (GO:0098581) | 2.58487531 |
| 132 | B cell mediated immunity (GO:0019724) | 2.58439607 |
| 133 | natural killer cell differentiation (GO:0001779) | 2.57723339 |
| 134 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.57545451 |
| 135 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.57057324 |
| 136 | tolerance induction (GO:0002507) | 2.57028728 |
| 137 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.56913939 |
| 138 | activation of MAPKKK activity (GO:0000185) | 2.56749763 |
| 139 | B cell homeostasis (GO:0001782) | 2.56672183 |
| 140 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.56615095 |
| 141 | DNA replication initiation (GO:0006270) | 2.55927153 |
| 142 | viral life cycle (GO:0019058) | 2.53995210 |
| 143 | negative regulation of cell size (GO:0045792) | 2.53707454 |
| 144 | respiratory burst (GO:0045730) | 2.53661951 |
| 145 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.53530516 |
| 146 | regulation of mast cell degranulation (GO:0043304) | 2.53209167 |
| 147 | response to interleukin-4 (GO:0070670) | 2.53082943 |
| 148 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.52615841 |
| 149 | mRNA splicing, via spliceosome (GO:0000398) | 2.52327321 |
| 150 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.52327321 |
| 151 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.52170963 |
| 152 | snRNA metabolic process (GO:0016073) | 2.51261975 |
| 153 | ribosomal small subunit biogenesis (GO:0042274) | 2.51021104 |
| 154 | negative regulation of interleukin-12 production (GO:0032695) | 2.50876441 |
| 155 | regulation of sister chromatid cohesion (GO:0007063) | 2.50648639 |
| 156 | positive regulation of granulocyte differentiation (GO:0030854) | 2.50052854 |
| 157 | positive regulation by host of viral transcription (GO:0043923) | 2.49960611 |
| 158 | chromatin silencing (GO:0006342) | 2.48913770 |
| 159 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.48823242 |
| 160 | regulation of leukocyte degranulation (GO:0043300) | 2.47999364 |
| 161 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.47897613 |
| 162 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.47561919 |
| 163 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.47277952 |
| 164 | T cell apoptotic process (GO:0070231) | 2.47053120 |
| 165 | translesion synthesis (GO:0019985) | 2.46563240 |
| 166 | cellular hyperosmotic response (GO:0071474) | 2.46475885 |
| 167 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.46414816 |
| 168 | nuclear envelope organization (GO:0006998) | 2.45947583 |
| 169 | RNA splicing, via transesterification reactions (GO:0000375) | 2.45890374 |
| 170 | protein targeting to ER (GO:0045047) | 2.45096146 |
| 171 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.44147928 |
| 172 | chromatin assembly (GO:0031497) | 2.44102422 |
| 173 | cellular protein complex disassembly (GO:0043624) | 2.42985498 |
| 174 | Golgi transport vesicle coating (GO:0048200) | 2.42172422 |
| 175 | COPI coating of Golgi vesicle (GO:0048205) | 2.42172422 |
| 176 | mitotic sister chromatid cohesion (GO:0007064) | 2.41244259 |
| 177 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.40833070 |
| 178 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.40833070 |
| 179 | RNA catabolic process (GO:0006401) | 2.40383497 |
| 180 | response to interleukin-15 (GO:0070672) | 2.40219763 |
| 181 | cotranslational protein targeting to membrane (GO:0006613) | 2.40024571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.88922946 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.68991720 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.58238201 |
| 4 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.34791299 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.97609900 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.52589953 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.50837059 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.36203208 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.32102472 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.18175840 |
| 11 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.11375752 |
| 12 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.11313714 |
| 13 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03521361 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.02414689 |
| 15 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 2.01632457 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.90375163 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.80403223 |
| 18 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79718928 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 1.79457911 |
| 20 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.77009972 |
| 21 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.76547654 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.71502033 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67994264 |
| 24 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62952222 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.62735449 |
| 26 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.61183498 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.55525201 |
| 28 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.55344966 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.55107919 |
| 30 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.54830736 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.52425172 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50801033 |
| 33 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.50795586 |
| 34 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.50608566 |
| 35 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.50595631 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.49375094 |
| 37 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47582670 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47182334 |
| 39 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.47131864 |
| 40 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.45098852 |
| 41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.41129390 |
| 42 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.40958782 |
| 43 | * MAF_26560356_Chip-Seq_TH2_Human | 1.40779006 |
| 44 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38963729 |
| 45 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.38569411 |
| 46 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37884292 |
| 47 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37754385 |
| 48 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.37418162 |
| 49 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.36507196 |
| 50 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35049722 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33276851 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.30772410 |
| 53 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.30631037 |
| 54 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.30382260 |
| 55 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.30368610 |
| 56 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.30165225 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.28675837 |
| 58 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28667220 |
| 59 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28309263 |
| 60 | * MYB_26560356_Chip-Seq_TH2_Human | 1.27151677 |
| 61 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.26643378 |
| 62 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.26260053 |
| 63 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26137258 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.25920526 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25408002 |
| 66 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25161009 |
| 67 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.24136909 |
| 68 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.22495546 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.22177146 |
| 70 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.22096494 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.21972763 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21739919 |
| 73 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.21094693 |
| 74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20227015 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19983550 |
| 76 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19151587 |
| 77 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.19109763 |
| 78 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19086471 |
| 79 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17803628 |
| 80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16884135 |
| 81 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.16123054 |
| 82 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16046489 |
| 83 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15912022 |
| 84 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.15750157 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15458273 |
| 86 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.15423732 |
| 87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15261922 |
| 88 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14410824 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14088487 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13986301 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.13722021 |
| 92 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13701831 |
| 93 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.13560759 |
| 94 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13124731 |
| 95 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.12881335 |
| 96 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12747306 |
| 97 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12366685 |
| 98 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.12033735 |
| 99 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.11428926 |
| 100 | P68_20966046_ChIP-Seq_HELA_Human | 1.10534812 |
| 101 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.10430598 |
| 102 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.10195311 |
| 103 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08904664 |
| 104 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08791039 |
| 105 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.07509493 |
| 106 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07175831 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07055199 |
| 108 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06952251 |
| 109 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.06229439 |
| 110 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.06058430 |
| 111 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.06052616 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05972592 |
| 113 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05889336 |
| 114 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05850607 |
| 115 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.05444193 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04621794 |
| 117 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03921260 |
| 118 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03715345 |
| 119 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02817968 |
| 120 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02537030 |
| 121 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02501588 |
| 122 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02497559 |
| 123 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02382175 |
| 124 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01982038 |
| 125 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.01789328 |
| 126 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.01753349 |
| 127 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.00856773 |
| 128 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99590801 |
| 129 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.98647716 |
| 130 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98475350 |
| 131 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.96468211 |
| 132 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95341920 |
| 133 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.95072073 |
| 134 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.93603829 |
| 135 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.93331439 |
| 136 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92751862 |
| 137 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.92351357 |
| 138 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.92203188 |
| 139 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92137358 |
| 140 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.91977975 |
| 141 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91374862 |
| 142 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.90661030 |
| 143 | * TTF2_22483619_ChIP-Seq_HELA_Human | 0.90641668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 2.88062274 |
| 2 | MP0005058_abnormal_lysosome_morphology | 2.76025596 |
| 3 | MP0009278_abnormal_bone_marrow | 2.62412631 |
| 4 | MP0003111_abnormal_nucleus_morphology | 2.60272732 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.44012096 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.43784466 |
| 7 | MP0003724_increased_susceptibility_to | 2.43549362 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.40995471 |
| 9 | MP0004957_abnormal_blastocyst_morpholog | 2.35338099 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.34139623 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.33151108 |
| 12 | MP0003077_abnormal_cell_cycle | 2.26448827 |
| 13 | MP0010094_abnormal_chromosome_stability | 2.25366247 |
| 14 | MP0008260_abnormal_autophagy | 2.24462997 |
| 15 | MP0002419_abnormal_innate_immunity | 2.22034250 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.16024272 |
| 17 | MP0003303_peritoneal_inflammation | 2.15993663 |
| 18 | MP0005451_abnormal_body_composition | 2.08237180 |
| 19 | MP0004808_abnormal_hematopoietic_stem | 2.01072913 |
| 20 | MP0009785_altered_susceptibility_to | 1.93592477 |
| 21 | MP0001730_embryonic_growth_arrest | 1.90261691 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 1.86148644 |
| 23 | MP0001545_abnormal_hematopoietic_system | 1.86148644 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.85490920 |
| 25 | MP0000685_abnormal_immune_system | 1.78454090 |
| 26 | MP0002398_abnormal_bone_marrow | 1.73512255 |
| 27 | MP0000703_abnormal_thymus_morphology | 1.72233143 |
| 28 | MP0005076_abnormal_cell_differentiation | 1.71822782 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.69933392 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.68798790 |
| 31 | MP0005083_abnormal_biliary_tract | 1.65486794 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.63590558 |
| 33 | MP0001873_stomach_inflammation | 1.62682229 |
| 34 | MP0002722_abnormal_immune_system | 1.52307281 |
| 35 | MP0000350_abnormal_cell_proliferation | 1.51995010 |
| 36 | MP0008961_abnormal_basal_metabolism | 1.51125570 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.48394705 |
| 38 | MP0008007_abnormal_cellular_replicative | 1.46077053 |
| 39 | MP0001800_abnormal_humoral_immune | 1.45906293 |
| 40 | MP0008877_abnormal_DNA_methylation | 1.42584884 |
| 41 | MP0006054_spinal_hemorrhage | 1.39237819 |
| 42 | MP0000490_abnormal_crypts_of | 1.38693838 |
| 43 | MP0005220_abnormal_exocrine_pancreas | 1.36847141 |
| 44 | MP0001672_abnormal_embryogenesis/_devel | 1.35994000 |
| 45 | MP0005380_embryogenesis_phenotype | 1.35994000 |
| 46 | MP0003984_embryonic_growth_retardation | 1.35837291 |
| 47 | MP0002088_abnormal_embryonic_growth/wei | 1.34955900 |
| 48 | MP0002019_abnormal_tumor_incidence | 1.34291216 |
| 49 | MP0010307_abnormal_tumor_latency | 1.32785882 |
| 50 | MP0002132_abnormal_respiratory_system | 1.31981367 |
| 51 | MP0008057_abnormal_DNA_replication | 1.31125951 |
| 52 | MP0004185_abnormal_adipocyte_glucose | 1.30997651 |
| 53 | MP0001697_abnormal_embryo_size | 1.30691862 |
| 54 | MP0001853_heart_inflammation | 1.30634467 |
| 55 | MP0002086_abnormal_extraembryonic_tissu | 1.28596024 |
| 56 | * MP0002080_prenatal_lethality | 1.28481054 |
| 57 | MP0002429_abnormal_blood_cell | 1.28271912 |
| 58 | MP0000716_abnormal_immune_system | 1.27877507 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.27469081 |
| 60 | MP0001790_abnormal_immune_system | 1.26377731 |
| 61 | MP0005387_immune_system_phenotype | 1.26377731 |
| 62 | MP0001851_eye_inflammation | 1.24735900 |
| 63 | MP0004197_abnormal_fetal_growth/weight/ | 1.21604849 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.21317664 |
| 65 | MP0002405_respiratory_system_inflammati | 1.21207290 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.21052578 |
| 67 | MP0002166_altered_tumor_susceptibility | 1.18664373 |
| 68 | MP0003283_abnormal_digestive_organ | 1.17658475 |
| 69 | MP0010030_abnormal_orbit_morphology | 1.16777267 |
| 70 | MP0009840_abnormal_foam_cell | 1.16323786 |
| 71 | MP0003191_abnormal_cellular_cholesterol | 1.14587865 |
| 72 | MP0002933_joint_inflammation | 1.13672906 |
| 73 | MP0003436_decreased_susceptibility_to | 1.13319826 |
| 74 | MP0000313_abnormal_cell_death | 1.12176172 |
| 75 | MP0008469_abnormal_protein_level | 1.12128658 |
| 76 | MP0002420_abnormal_adaptive_immunity | 1.11516078 |
| 77 | MP0003252_abnormal_bile_duct | 1.11009780 |
| 78 | MP0005365_abnormal_bile_salt | 1.10633821 |
| 79 | * MP0002085_abnormal_embryonic_tissue | 1.08688464 |
| 80 | MP0001348_abnormal_lacrimal_gland | 1.08345697 |
| 81 | MP0001819_abnormal_immune_cell | 1.07638341 |
| 82 | MP0001915_intracranial_hemorrhage | 1.07142541 |
| 83 | MP0004510_myositis | 1.06983268 |
| 84 | MP0002452_abnormal_antigen_presenting | 1.06797406 |
| 85 | MP0006082_CNS_inflammation | 1.06608787 |
| 86 | MP0005023_abnormal_wound_healing | 1.06077843 |
| 87 | * MP0002084_abnormal_developmental_patter | 1.05151800 |
| 88 | MP0004947_skin_inflammation | 1.03770772 |
| 89 | MP0009672_abnormal_birth_weight | 1.02615394 |
| 90 | MP0002723_abnormal_immune_serum | 1.00066303 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.99761148 |
| 92 | MP0005670_abnormal_white_adipose | 0.99697766 |
| 93 | MP0000003_abnormal_adipose_tissue | 0.98166338 |
| 94 | MP0002138_abnormal_hepatobiliary_system | 0.98143023 |
| 95 | MP0001849_ear_inflammation | 0.97305682 |
| 96 | MP0004264_abnormal_extraembryonic_tissu | 0.97036253 |
| 97 | MP0000858_altered_metastatic_potential | 0.96981741 |
| 98 | MP0005671_abnormal_response_to | 0.96866378 |
| 99 | MP0004381_abnormal_hair_follicle | 0.96743484 |
| 100 | MP0000598_abnormal_liver_morphology | 0.95935937 |
| 101 | MP0003656_abnormal_erythrocyte_physiolo | 0.95180356 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.94783241 |
| 103 | MP0005310_abnormal_salivary_gland | 0.94344461 |
| 104 | MP0005464_abnormal_platelet_physiology | 0.93976446 |
| 105 | MP0008058_abnormal_DNA_repair | 0.93079066 |
| 106 | MP0003123_paternal_imprinting | 0.92749851 |
| 107 | MP0000733_abnormal_muscle_development | 0.92213108 |
| 108 | MP0000678_abnormal_parathyroid_gland | 0.89716474 |
| 109 | MP0001666_abnormal_nutrient_absorption | 0.89443526 |
| 110 | MP0000609_abnormal_liver_physiology | 0.89332460 |
| 111 | MP0003075_altered_response_to | 0.88927839 |
| 112 | MP0005375_adipose_tissue_phenotype | 0.87775815 |
| 113 | MP0010630_abnormal_cardiac_muscle | 0.87738798 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.82543605 |
| 115 | MP0003866_abnormal_defecation | 0.82376489 |
| 116 | MP0001845_abnormal_inflammatory_respons | 0.82366609 |
| 117 | MP0005621_abnormal_cell_physiology | 0.82344995 |
| 118 | MP0002653_abnormal_ependyma_morphology | 0.82066221 |
| 119 | MP0005360_urolithiasis | 0.81877874 |
| 120 | MP0008995_early_reproductive_senescence | 0.81077232 |
| 121 | MP0010368_abnormal_lymphatic_system | 0.80520109 |
| 122 | MP0004858_abnormal_nervous_system | 0.80289019 |
| 123 | MP0003567_abnormal_fetal_cardiomyocyte | 0.80275850 |
| 124 | MP0000477_abnormal_intestine_morphology | 0.80160362 |
| 125 | MP0008874_decreased_physiological_sensi | 0.80061567 |
| 126 | MP0005025_abnormal_response_to | 0.79411139 |
| 127 | MP0002925_abnormal_cardiovascular_devel | 0.77365926 |
| 128 | MP0009931_abnormal_skin_appearance | 0.77060727 |
| 129 | MP0005390_skeleton_phenotype | 0.76974083 |
| 130 | MP0003115_abnormal_respiratory_system | 0.76565332 |
| 131 | MP0000604_amyloidosis | 0.75250203 |
| 132 | MP0002139_abnormal_hepatobiliary_system | 0.74619114 |
| 133 | MP0005000_abnormal_immune_tolerance | 0.74036075 |
| 134 | MP0003119_abnormal_digestive_system | 0.73715373 |
| 135 | MP0002089_abnormal_postnatal_growth/wei | 0.73021851 |
| 136 | MP0001835_abnormal_antigen_presentation | 0.72910962 |
| 137 | MP0003091_abnormal_cell_migration | 0.72813399 |
| 138 | MP0003329_amyloid_beta_deposits | 0.72487242 |
| 139 | MP0005166_decreased_susceptibility_to | 0.68892072 |
| 140 | MP0003786_premature_aging | 0.67770509 |
| 141 | MP0005075_abnormal_melanosome_morpholog | 0.66291162 |
| 142 | MP0002877_abnormal_melanocyte_morpholog | 0.66182532 |
| 143 | MP0009763_increased_sensitivity_to | 0.64704765 |
| 144 | MP0001663_abnormal_digestive_system | 0.64243797 |
| 145 | MP0003806_abnormal_nucleotide_metabolis | 0.63823954 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.52756577 |
| 2 | Agammaglobulinemia (HP:0004432) | 3.75758147 |
| 3 | Abnormality of the fingertips (HP:0001211) | 3.69174903 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.64269971 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.42703712 |
| 6 | Increased IgE level (HP:0003212) | 3.39132788 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 3.37569249 |
| 8 | Meningitis (HP:0001287) | 3.34168250 |
| 9 | Nasal polyposis (HP:0100582) | 3.33965173 |
| 10 | Myositis (HP:0100614) | 3.26467356 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.24901431 |
| 12 | Abnormality of the nasal mucosa (HP:0000433) | 3.20551710 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.08030544 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.03881558 |
| 15 | Obstructive lung disease (HP:0006536) | 3.03881558 |
| 16 | Hyperacusis (HP:0010780) | 3.03570902 |
| 17 | Gastrointestinal stroma tumor (HP:0100723) | 2.99243877 |
| 18 | Long eyelashes (HP:0000527) | 2.98016341 |
| 19 | Increased density of long bones (HP:0006392) | 2.97653115 |
| 20 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.94824820 |
| 21 | Short 4th metacarpal (HP:0010044) | 2.94824820 |
| 22 | Hypertensive crisis (HP:0100735) | 2.89793095 |
| 23 | T lymphocytopenia (HP:0005403) | 2.87842821 |
| 24 | Combined immunodeficiency (HP:0005387) | 2.73489721 |
| 25 | Rectal prolapse (HP:0002035) | 2.65207904 |
| 26 | Abnormality of T cell number (HP:0011839) | 2.62565886 |
| 27 | Cerebral aneurysm (HP:0004944) | 2.62060205 |
| 28 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.60911631 |
| 29 | Selective tooth agenesis (HP:0001592) | 2.60822772 |
| 30 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58665667 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.52090282 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 2.50624022 |
| 33 | Colon cancer (HP:0003003) | 2.49102567 |
| 34 | Abnormal number of erythroid precursors (HP:0012131) | 2.49059859 |
| 35 | Dysostosis multiplex (HP:0000943) | 2.49038091 |
| 36 | Petechiae (HP:0000967) | 2.44514862 |
| 37 | Basal cell carcinoma (HP:0002671) | 2.44423281 |
| 38 | Severe combined immunodeficiency (HP:0004430) | 2.43516802 |
| 39 | Abnormality of the 4th metacarpal (HP:0010012) | 2.42269772 |
| 40 | Reticulocytopenia (HP:0001896) | 2.42269113 |
| 41 | Granulocytopenia (HP:0001913) | 2.41795614 |
| 42 | Osteomyelitis (HP:0002754) | 2.41666143 |
| 43 | Hepatosplenomegaly (HP:0001433) | 2.40579690 |
| 44 | Polygenic inheritance (HP:0010982) | 2.38959721 |
| 45 | Emphysema (HP:0002097) | 2.38515749 |
| 46 | Gingivitis (HP:0000230) | 2.38438152 |
| 47 | IgM deficiency (HP:0002850) | 2.38003888 |
| 48 | Bicuspid aortic valve (HP:0001647) | 2.37400249 |
| 49 | Recurrent bronchitis (HP:0002837) | 2.36519377 |
| 50 | Vasculitis (HP:0002633) | 2.36060555 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 2.34435825 |
| 52 | Systemic lupus erythematosus (HP:0002725) | 2.33978465 |
| 53 | Papilloma (HP:0012740) | 2.33743372 |
| 54 | Verrucae (HP:0200043) | 2.33743372 |
| 55 | Ependymoma (HP:0002888) | 2.32143799 |
| 56 | Urticaria (HP:0001025) | 2.30052497 |
| 57 | Recurrent viral infections (HP:0004429) | 2.30040750 |
| 58 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.28944852 |
| 59 | Thrombocytosis (HP:0001894) | 2.28771146 |
| 60 | Abnormality of T cells (HP:0002843) | 2.26576254 |
| 61 | Increased serum ferritin (HP:0003281) | 2.25680038 |
| 62 | Recurrent skin infections (HP:0001581) | 2.25429274 |
| 63 | Gastrointestinal infarctions (HP:0005244) | 2.25338742 |
| 64 | Orchitis (HP:0100796) | 2.25130080 |
| 65 | Hypergammaglobulinemia (HP:0010702) | 2.23806976 |
| 66 | Cellulitis (HP:0100658) | 2.23560574 |
| 67 | Loss of speech (HP:0002371) | 2.22689173 |
| 68 | Shallow orbits (HP:0000586) | 2.22159502 |
| 69 | High pitched voice (HP:0001620) | 2.21339445 |
| 70 | Sepsis (HP:0100806) | 2.17654084 |
| 71 | Progressive external ophthalmoplegia (HP:0000590) | 2.17640729 |
| 72 | Increased nuchal translucency (HP:0010880) | 2.17004123 |
| 73 | Chest pain (HP:0100749) | 2.16237861 |
| 74 | Stomatitis (HP:0010280) | 2.15664672 |
| 75 | Multiple enchondromatosis (HP:0005701) | 2.12775003 |
| 76 | Recurrent cutaneous fungal infections (HP:0011370) | 2.12660555 |
| 77 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.12660555 |
| 78 | Pustule (HP:0200039) | 2.12214761 |
| 79 | Broad face (HP:0000283) | 2.10392446 |
| 80 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.07592583 |
| 81 | Skin tags (HP:0010609) | 2.07370229 |
| 82 | Hypertriglyceridemia (HP:0002155) | 2.05812628 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.04400736 |
| 84 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.02836267 |
| 85 | Obstructive sleep apnea (HP:0002870) | 2.01397931 |
| 86 | Proximal placement of thumb (HP:0009623) | 2.01329241 |
| 87 | Metaphyseal cupping (HP:0003021) | 2.01117108 |
| 88 | Facial hemangioma (HP:0000329) | 2.00883646 |
| 89 | Purpura (HP:0000979) | 2.00315448 |
| 90 | Restrictive lung disease (HP:0002091) | 1.99016536 |
| 91 | Encephalitis (HP:0002383) | 1.98978311 |
| 92 | Epistaxis (HP:0000421) | 1.98678896 |
| 93 | Trigonocephaly (HP:0000243) | 1.98414834 |
| 94 | Thoracic kyphosis (HP:0002942) | 1.98347084 |
| 95 | Polycythemia (HP:0001901) | 1.98125939 |
| 96 | Distal lower limb amyotrophy (HP:0008944) | 1.98027594 |
| 97 | Recurrent lower respiratory tract infections (HP:0002783) | 1.97766081 |
| 98 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.97086220 |
| 99 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.97086220 |
| 100 | Abnormality of glycolipid metabolism (HP:0010969) | 1.97086220 |
| 101 | Hemorrhage of the eye (HP:0011885) | 1.96931050 |
| 102 | Colitis (HP:0002583) | 1.95413626 |
| 103 | Panhypogammaglobulinemia (HP:0003139) | 1.94677329 |
| 104 | Seborrheic dermatitis (HP:0001051) | 1.94632730 |
| 105 | Renal duplication (HP:0000075) | 1.94402586 |
| 106 | Short 1st metacarpal (HP:0010034) | 1.94260909 |
| 107 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.94260909 |
| 108 | Skin ulcer (HP:0200042) | 1.93577031 |
| 109 | Gastrointestinal dysmotility (HP:0002579) | 1.93108931 |
| 110 | Impaired platelet aggregation (HP:0003540) | 1.92877868 |
| 111 | Abnormal platelet function (HP:0011869) | 1.92877868 |
| 112 | Cholecystitis (HP:0001082) | 1.92689502 |
| 113 | Abnormal gallbladder physiology (HP:0012438) | 1.92689502 |
| 114 | Cutis marmorata (HP:0000965) | 1.92401395 |
| 115 | Recurrent sinusitis (HP:0011108) | 1.91719088 |
| 116 | Microretrognathia (HP:0000308) | 1.91492355 |
| 117 | Slow saccadic eye movements (HP:0000514) | 1.91471629 |
| 118 | Prominent nose (HP:0000448) | 1.90163900 |
| 119 | Elfin facies (HP:0004428) | 1.88857087 |
| 120 | Short phalanx of the thumb (HP:0009660) | 1.88041219 |
| 121 | Deviation of the thumb (HP:0009603) | 1.87975304 |
| 122 | Difficulty climbing stairs (HP:0003551) | 1.87178559 |
| 123 | Medulloblastoma (HP:0002885) | 1.86977649 |
| 124 | Pulmonary infiltrates (HP:0002113) | 1.86421174 |
| 125 | Interstitial pulmonary disease (HP:0006530) | 1.85985495 |
| 126 | Abnormality of reticulocytes (HP:0004312) | 1.85896819 |
| 127 | Malnutrition (HP:0004395) | 1.85749631 |
| 128 | Chronic otitis media (HP:0000389) | 1.85594318 |
| 129 | Optic neuritis (HP:0100653) | 1.84432236 |
| 130 | Retrobulbar optic neuritis (HP:0100654) | 1.84432236 |
| 131 | Broad palm (HP:0001169) | 1.83290182 |
| 132 | Arterial thrombosis (HP:0004420) | 1.82989551 |
| 133 | Recurrent fungal infections (HP:0002841) | 1.82980999 |
| 134 | Peripheral hypomyelination (HP:0007182) | 1.82817598 |
| 135 | Hand muscle atrophy (HP:0009130) | 1.82036757 |
| 136 | Myopathic facies (HP:0002058) | 1.82017624 |
| 137 | Hemoptysis (HP:0002105) | 1.81969077 |
| 138 | Biconcave vertebral bodies (HP:0004586) | 1.80448398 |
| 139 | Thyroiditis (HP:0100646) | 1.80253940 |
| 140 | Protrusio acetabuli (HP:0003179) | 1.79558805 |
| 141 | Long palpebral fissure (HP:0000637) | 1.79123442 |
| 142 | Abnormality of the thoracic spine (HP:0100711) | 1.78978034 |
| 143 | Preauricular skin tag (HP:0000384) | 1.78948591 |
| 144 | Ragged-red muscle fibers (HP:0003200) | 1.78903352 |
| 145 | Renovascular hypertension (HP:0100817) | 1.78669215 |
| 146 | Recurrent pneumonia (HP:0006532) | 1.78663122 |
| 147 | Abnormal number of incisors (HP:0011064) | 1.78495374 |
| 148 | Reticulocytosis (HP:0001923) | 1.77963760 |
| 149 | Spontaneous hematomas (HP:0007420) | 1.74151419 |
| 150 | Mitral valve prolapse (HP:0001634) | 1.72353291 |
| 151 | Autoimmune thrombocytopenia (HP:0001973) | 1.72275687 |
| 152 | Insomnia (HP:0100785) | 1.71940477 |
| 153 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.71146539 |
| 154 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.71146539 |
| 155 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.70408458 |
| 156 | Abnormality of the peritoneum (HP:0002585) | 1.68980387 |
| 157 | Deep venous thrombosis (HP:0002625) | 1.68711802 |
| 158 | Aplastic anemia (HP:0001915) | 1.67108657 |
| 159 | Abnormality of the metopic suture (HP:0005556) | 1.66308547 |
| 160 | Prolonged bleeding time (HP:0003010) | 1.65223648 |
| 161 | Progressive muscle weakness (HP:0003323) | 1.64707721 |
| 162 | Short palpebral fissure (HP:0012745) | 1.64535313 |
| 163 | Aortic aneurysm (HP:0004942) | 1.64292197 |
| 164 | Ulnar bowing (HP:0003031) | 1.63929165 |
| 165 | Lymphopenia (HP:0001888) | 1.63898432 |
| 166 | Trismus (HP:0000211) | 1.63615979 |
| 167 | Atresia of the external auditory canal (HP:0000413) | 1.63308648 |
| 168 | Fatigue (HP:0012378) | 1.62601217 |
| 169 | Late onset (HP:0003584) | 1.60821252 |
| 170 | Spastic diplegia (HP:0001264) | 1.60465379 |
| 171 | Mesangial abnormality (HP:0001966) | 1.60424501 |
| 172 | Ectopic kidney (HP:0000086) | 1.59993023 |
| 173 | Ureteral stenosis (HP:0000071) | 1.59848421 |
| 174 | Abnormality of the 1st metacarpal (HP:0010009) | 1.59527398 |
| 175 | Distal upper limb amyotrophy (HP:0007149) | 1.58552809 |
| 176 | Upper limb amyotrophy (HP:0009129) | 1.58552809 |
| 177 | Cerebellar dysplasia (HP:0007033) | 1.58034977 |
| 178 | Bronchitis (HP:0012387) | 1.58025588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 3.98516593 |
| 2 | TRIB3 | 3.83240369 |
| 3 | EEF2K | 3.72044701 |
| 4 | PKN2 | 3.40450277 |
| 5 | PRPF4B | 3.37980729 |
| 6 | SMG1 | 3.24584826 |
| 7 | MAP4K1 | 3.10587044 |
| 8 | CDK12 | 2.80499128 |
| 9 | ERN1 | 2.73912147 |
| 10 | RIPK4 | 2.45844114 |
| 11 | NEK2 | 2.21842805 |
| 12 | BRD4 | 2.14774808 |
| 13 | CDC7 | 1.99131684 |
| 14 | STK10 | 1.93754029 |
| 15 | MAP3K13 | 1.85490422 |
| 16 | PASK | 1.82974434 |
| 17 | GRK6 | 1.79460862 |
| 18 | MAP3K14 | 1.71989557 |
| 19 | RPS6KA4 | 1.63551293 |
| 20 | TNK2 | 1.61615341 |
| 21 | LRRK2 | 1.60413955 |
| 22 | KDR | 1.59530568 |
| 23 | CDK4 | 1.59115641 |
| 24 | ZAP70 | 1.57280291 |
| 25 | PTK6 | 1.51150344 |
| 26 | FGFR4 | 1.43492446 |
| 27 | FES | 1.38046427 |
| 28 | IRAK4 | 1.37855011 |
| 29 | BLK | 1.37601747 |
| 30 | MAP3K3 | 1.33827978 |
| 31 | RPS6KB2 | 1.32899655 |
| 32 | MAP2K3 | 1.30300721 |
| 33 | ICK | 1.28710627 |
| 34 | SCYL2 | 1.28232643 |
| 35 | BCKDK | 1.25949987 |
| 36 | PAK4 | 1.22379147 |
| 37 | BUB1 | 1.17031538 |
| 38 | PIM1 | 1.16241418 |
| 39 | CDK9 | 1.15876586 |
| 40 | SIK3 | 1.14011222 |
| 41 | TTN | 1.11676247 |
| 42 | SIK1 | 1.09748020 |
| 43 | MAP3K8 | 1.08191021 |
| 44 | MTOR | 1.07377436 |
| 45 | MARK2 | 1.07149815 |
| 46 | TAOK1 | 1.02145280 |
| 47 | KIT | 1.00778385 |
| 48 | TESK2 | 0.99838088 |
| 49 | TAOK2 | 0.99681589 |
| 50 | CDK6 | 0.98708574 |
| 51 | IRAK3 | 0.95980077 |
| 52 | STK4 | 0.95255507 |
| 53 | FLT3 | 0.94672696 |
| 54 | FGR | 0.94392886 |
| 55 | TYK2 | 0.94379724 |
| 56 | BTK | 0.93847555 |
| 57 | JAK3 | 0.91336953 |
| 58 | TGFBR1 | 0.90712990 |
| 59 | CDK7 | 0.89313327 |
| 60 | RIPK1 | 0.89139342 |
| 61 | PRKD2 | 0.88451145 |
| 62 | MAP3K1 | 0.88173196 |
| 63 | ALK | 0.86658088 |
| 64 | ITK | 0.86587893 |
| 65 | WEE1 | 0.86246714 |
| 66 | IKBKB | 0.85467116 |
| 67 | CHUK | 0.84042514 |
| 68 | VRK2 | 0.79074498 |
| 69 | DYRK1B | 0.78496216 |
| 70 | MAP3K7 | 0.78140879 |
| 71 | LYN | 0.76949102 |
| 72 | CDC42BPA | 0.76380632 |
| 73 | MAPK15 | 0.75995593 |
| 74 | AURKB | 0.72648244 |
| 75 | ARAF | 0.72387352 |
| 76 | TGFBR2 | 0.71516586 |
| 77 | CHEK1 | 0.71484116 |
| 78 | MAPKAPK3 | 0.70913604 |
| 79 | MAPK12 | 0.70793661 |
| 80 | EIF2AK1 | 0.70214876 |
| 81 | MATK | 0.70171183 |
| 82 | PDGFRA | 0.69807614 |
| 83 | RPS6KC1 | 0.69604366 |
| 84 | RPS6KL1 | 0.69604366 |
| 85 | DYRK3 | 0.69513987 |
| 86 | ATR | 0.69217495 |
| 87 | MAP2K2 | 0.67755035 |
| 88 | MAP3K6 | 0.66957456 |
| 89 | MAPK11 | 0.66892924 |
| 90 | BMX | 0.66783857 |
| 91 | PRKCH | 0.66223994 |
| 92 | PDPK1 | 0.65732088 |
| 93 | CSK | 0.65392968 |
| 94 | NEK1 | 0.64476562 |
| 95 | EPHB1 | 0.63006898 |
| 96 | FGFR3 | 0.62940295 |
| 97 | NLK | 0.62300475 |
| 98 | TTK | 0.62119636 |
| 99 | TBK1 | 0.61471213 |
| 100 | SIK2 | 0.60037658 |
| 101 | JAK1 | 0.59665529 |
| 102 | PDK1 | 0.58870290 |
| 103 | MARK3 | 0.57999494 |
| 104 | TAOK3 | 0.57965478 |
| 105 | PAK2 | 0.57916288 |
| 106 | PLK1 | 0.57847006 |
| 107 | PIM2 | 0.57585625 |
| 108 | TYRO3 | 0.54893714 |
| 109 | CAMK1G | 0.54736531 |
| 110 | CDK2 | 0.54319362 |
| 111 | RPS6KA1 | 0.53331706 |
| 112 | CAMK1D | 0.53204319 |
| 113 | MAPK7 | 0.52185866 |
| 114 | JAK2 | 0.51603831 |
| 115 | CSF1R | 0.51576092 |
| 116 | RPS6KA2 | 0.51525037 |
| 117 | DAPK1 | 0.51418210 |
| 118 | PRKD3 | 0.50892675 |
| 119 | MAPKAPK2 | 0.50856964 |
| 120 | IKBKE | 0.48962841 |
| 121 | MAPK4 | 0.46559149 |
| 122 | CAMKK1 | 0.46034075 |
| 123 | HIPK2 | 0.45792181 |
| 124 | MAP3K11 | 0.45709773 |
| 125 | TESK1 | 0.45609883 |
| 126 | FGFR1 | 0.45316785 |
| 127 | NME2 | 0.45022977 |
| 128 | SYK | 0.44919636 |
| 129 | ILK | 0.43407890 |
| 130 | HCK | 0.41668219 |
| 131 | LCK | 0.39804471 |
| 132 | MAP2K6 | 0.38831623 |
| 133 | CCNB1 | 0.38689667 |
| 134 | KSR2 | 0.38112239 |
| 135 | ACVR1B | 0.38021645 |
| 136 | LATS1 | 0.37668727 |
| 137 | BRSK2 | 0.36602158 |
| 138 | MELK | 0.36395078 |
| 139 | RPS6KA6 | 0.35395676 |
| 140 | TXK | 0.34730942 |
| 141 | TSSK6 | 0.32857473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.49372960 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.11965284 |
| 3 | Spliceosome_Homo sapiens_hsa03040 | 2.56648567 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.37865792 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.36709961 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.36319168 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.13849530 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.12496589 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 1.98887420 |
| 10 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.95485818 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.89865236 |
| 12 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.87451644 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.86921519 |
| 14 | Cell cycle_Homo sapiens_hsa04110 | 1.80189213 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.77799766 |
| 16 | Lysine degradation_Homo sapiens_hsa00310 | 1.71298478 |
| 17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.62058467 |
| 18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.61152528 |
| 19 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.58945332 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58238624 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.57719222 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.53814760 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49195866 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48398102 |
| 25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.44869007 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39945490 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.38392026 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.36227342 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34176133 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28065525 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.27338349 |
| 32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.26883788 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.26240255 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.26029992 |
| 35 | HTLV-I infection_Homo sapiens_hsa05166 | 1.24493000 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21483801 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.20187493 |
| 38 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.19778742 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.16997863 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15788957 |
| 41 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.13404700 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12061555 |
| 43 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.11760412 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11598918 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.11547969 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.08929912 |
| 47 | Colorectal cancer_Homo sapiens_hsa05210 | 1.08740498 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.05376684 |
| 49 | Leishmaniasis_Homo sapiens_hsa05140 | 1.04456939 |
| 50 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.04114583 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.03412187 |
| 52 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.02239217 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99384439 |
| 54 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.98118616 |
| 55 | Homologous recombination_Homo sapiens_hsa03440 | 0.98055339 |
| 56 | Measles_Homo sapiens_hsa05162 | 0.97251678 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96834109 |
| 58 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.96087802 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95603298 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 0.95542702 |
| 61 | Thyroid cancer_Homo sapiens_hsa05216 | 0.95474225 |
| 62 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.92687615 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91030019 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.90852902 |
| 65 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.90846204 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90742817 |
| 67 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.89885638 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89458903 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88677264 |
| 70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.88674891 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.86672614 |
| 72 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.85912643 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.85574688 |
| 74 | Malaria_Homo sapiens_hsa05144 | 0.84965037 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.84939964 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84240132 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83169842 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.82764703 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82576146 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81651502 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81559759 |
| 82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81383868 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.80915794 |
| 84 | Hepatitis B_Homo sapiens_hsa05161 | 0.80607304 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79857171 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.79092479 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.77581634 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.74006776 |
| 89 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.73765265 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73313957 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73309707 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.73009086 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72512290 |
| 94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72413430 |
| 95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72264012 |
| 96 | Influenza A_Homo sapiens_hsa05164 | 0.72063497 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71972937 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71920810 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71704083 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70892012 |
| 101 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69005759 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.68843055 |
| 103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68323751 |
| 104 | Shigellosis_Homo sapiens_hsa05131 | 0.67067856 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.66292739 |
| 106 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65849947 |
| 107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65846356 |
| 108 | Salmonella infection_Homo sapiens_hsa05132 | 0.64856532 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64817775 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.63681970 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63535479 |
| 112 | Phagosome_Homo sapiens_hsa04145 | 0.63197226 |
| 113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62312716 |
| 114 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.62020251 |
| 115 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.61063560 |
| 116 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.58714231 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57128825 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56321232 |
| 119 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.56159031 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56112671 |
| 121 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.55326761 |
| 122 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.54942218 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.53668595 |
| 124 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53078209 |
| 125 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51084809 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50838219 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50585605 |
| 128 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50244683 |
| 129 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49929232 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.49256566 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47339960 |
| 132 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47339474 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46665590 |
| 134 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46381884 |
| 135 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.46320583 |
| 136 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45846455 |
| 137 | Prostate cancer_Homo sapiens_hsa05215 | 0.45165854 |
| 138 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.45134643 |
| 139 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44569443 |
| 140 | Glioma_Homo sapiens_hsa05214 | 0.43987897 |
| 141 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43210716 |
| 142 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41808226 |

